After Failure, California Legislative Psychedelics Advocates Hold Out Hope for 2026
Despite failing earlier this year, California's legislative psychedelic advocates are eyeing 2026 as the year to push through legalization.
Read MoreLegalization updates, FDA decisions, state laws, decriminalization, and regulatory news.
Despite failing earlier this year, California's legislative psychedelic advocates are eyeing 2026 as the year to push through legalization.
Read More
Insurance Business, a trade publication for the insurance sector, is now telling insurers to pay closer attention to psychedelic medicine.
Read More
Democratic Congressman Lou Correa believes the Trump administration presents an unprecedented opportunity to transform American drug policy.
Read More
The FDA finalized its first formal guidance for studying psychedelic drugs. The document sets the ground rules for research into
Read More
Ibogaine's cardiac risk is real. The Stanford MISTIC protocol has reshaped the picture. A complete 2026 guide to screening, monitoring,
Read More
Following in the footsteps of Oregon and Colorado, Massachusetts is voting to legalize psychedelics this election.
Read More
Gov. Ned Lamont has signed Senate Bill 191, a measure that expands the state’s existing psychedelic therapy pilot program.
Read More
Despite growing concerns about policy changes, psychedelic decriminalization has not triggered a wave of hospital visits.
Read More
The executive order mentions ibogaine, but psilocybin may be the real winner. How priority vouchers, Right to Try, and rescheduling
Read More
We broke down the pro and anti arguments being made in the media on the Massachusetts Bill to legalize psychedelics.
Read More